The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.
The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
I was recently invited to try SomaCell, a groundbreaking new FDA-cleared treatment that promises to take years off your face ...